Page last updated: 2024-09-04

1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone and Parkinson Disease

1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Baghdadi, OB; Geldenhuys, WJ; Prater, NI; Van der Schyf, CJ1

Other Studies

1 other study(ies) available for 1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone and Parkinson Disease

ArticleYear
Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson's disease.
    Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

    Topics: Alkaloids; Animals; Benzodioxoles; Binding Sites; Blood-Brain Barrier; Cattle; Humans; Hydrogen Bonding; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Piper nigrum; Piperidines; Polyunsaturated Alkamides; Protein Binding; Protein Structure, Tertiary; Serum Albumin, Bovine

2012